Guillaume Bailly

Social SciencesEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Immune checkpoint inhibitor-associated myocarditis: a novel risk score”.

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

European Heart Journal(2025)10.1093/eurheartj/ehaf315

N/A

1.1DataRank · unranked

47 citations

Charles Dolladille, Benay Ozbay, Adrien Procureur, Stéphane Éderhy, Nicolas L. Palaskas +92 more

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Circulation(2023)10.1161/circulationaha.123.062405

N/A

0.753DataRank · unranked

150 citations

Markus Heckmann, Guillaume Bailly, Daniel Finke, Adrien Procureur, John R. Power +58 more

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction

JACC CardioOncology(2025)10.1016/j.jaccao.2025.01.020

N/A

0.470DataRank · unranked

22 citations

Charles Dolladille, Anjali Rao, Nicolas L. Palaskas, Anita Deswal, Lorenz Lehmann +51 more

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

medRxiv(2024)10.1101/2024.06.02.24308336

N/A

0.383DataRank · unranked

6 citations

Charles Dolladille, Adriel Procureur, Stéphane Éderhy, Nicolas L. Palaskas, Lorenz Lehmann +47 more

Discrepancies of cardio-muscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor (ICI)-associated myocarditis

Research Square(2022)10.21203/rs.3.rs-2030687/v1

N/A

0DataRank · unranked

1 citations

Markus Heckmann, Guillaume Bailly, Daniel Finke, Frederic Stein, John R. Power +17 more